AERIE PHARMACEUTICALS INC Annual Costs and Expenses in USD from 2016 to 2021

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from 2016 to 2021.
  • Aerie Pharmaceuticals Inc Costs and Expenses for the quarter ending September 30, 2022 was $62.8M, a 1.81% increase year-over-year.
  • Aerie Pharmaceuticals Inc Costs and Expenses for the twelve months ending September 30, 2022 was $241M, a 1.18% increase year-over-year.
  • Aerie Pharmaceuticals Inc annual Costs and Expenses for 2021 was $240M, a 0.7% increase from 2020.
  • Aerie Pharmaceuticals Inc annual Costs and Expenses for 2020 was $239M, a 7.21% decline from 2019.
  • Aerie Pharmaceuticals Inc annual Costs and Expenses for 2019 was $257M, a 10% increase from 2018.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $240M +$1.66M +0.7% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-25
2020 $239M -$18.6M -7.21% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 $257M +$23.5M +10% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $234M +$88.2M +60.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $146M +$48.8M +50.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $96.9M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.